Columbia University is one of the leading programs in the United States conducting a groundbreaking Phase 2 clinical trial of an investigational gene therapy for dry age-related macular degeneration.

NewYork-Presbyterian obstetricians and gynecologists continue to investigate COVID-19 and its potential impact on pregnancy outcomes, including studies on serial testing for SARS-CoV-2 and vaccinations.

Neurologists and critical care medicine specialists at NewYork-Presbyterian Hospital offer highly specialized expertise in disorders of consciousness to promote the best outcomes for patients.

Oncologists and other specialists at NewYork-Presbyterian Hospital continue to contribute their expertise and resources to scientific investigations of COVID-19 and its implications for oncology care.

Research by Adam Mor, MD, PhD, a rheumatologist and molecular immunologist at NewYork-Presbyterian/Columbia University Irving Medical Center, focuses on the function of T lymphocytes in autoimmune disease and cancer

Research sites work collaboratively to define shared and disease-specific biological pathways in order to identify relevant drug targets for the treatment of rheumatoid arthritis, lupus, and related autoimmune diseases.

In the rapidly evolving field of cardio-oncology, NewYork-Presbyterian Hospital is making its mark with dedicated programs led by cardiology faculty at Columbia University Vagelos College of Physicians and Surgeons and Weill Cornell Medicine.

Our sports medicine physicians, many of whom have been competitive athletes, have a distinguished record of returning players to their sport in optimal form.